Paraoxonase 2 PON2Âappears to play a cardioprotective role in both human and experimental heart failure CardiologistÂWai Hong Wilson Tang MD Director of Cleveland Clinic Lerner Research Institutes Center for Clinical Genomics.

Paraoxonase 2 (PON2) appears to play a cardioprotective role in both human and experimental heart failure: Cardiologist Wai Hong Wilson Tang, MD, Director of Cleveland Clinic Lerner Research Institute’s Center for Clinical Genomics.

14:04 EST 1 Jan 2019 | Leaders in Pharmaceutical Business Intelligence

Paraoxonase 2 (PON2) appears to play a cardioprotective role in both human and experimental heart failure: Cardiologist Wai Hong Wilson Tang, MD, Director of Cleveland Clinic Lerner Research Institute’s Center for Clinical Genomics. Reporter: Aviva Lev-Ari, PhD, RN Enzyme Protects Heart Against Stress and Could Potentially Lead to New Heart Failure Treatments https://consultqd.clevelandclinic.org/enzyme-protects-heart-against-stress-and-could-potentially-lead-to-new-heart-failure-treatments/amp/?__twitter_impression=true Categories: Basic Research, Heart & Vascular, Research […]

More From BioPortfolio on "Paraoxonase 2 (PON2) appears to play a cardioprotective role in both human and experimental heart failure: Cardiologist Wai Hong Wilson Tang, MD, Director of Cleveland Clinic Lerner Research Institute’s Center for Clinical Genomics."